The microbial identification market has seen considerable growth due to a variety of factors.
• The microbial identification market has grown rapidly in recent years. It will increase from $5.57 billion in 2024 to $6.44 billion in 2025, reflecting a CAGR of 15.7%.
The growth is attributed to government initiatives and funding for promoting microbial identification, an increase in FDA approvals, and growing health awareness.
The microbial identification market is expected to maintain its strong growth trajectory in upcoming years.
• The microbial identification market is projected to grow rapidly, reaching $11.44 billion by 2029 at a CAGR of 15.4%.
This growth is driven by increased concerns about food safety, the rising incidence of infectious diseases, and the higher frequency of pandemics. Key trends include technological improvements in microbial identification, ongoing automation developments, advancements in molecular diagnostics, genomics, and collaborations.
The increasing incidence of infectious diseases is anticipated to drive the growth of the microbial identification market. Infectious diseases are caused by harmful microorganisms like bacteria, viruses, fungi, parasites, and prions. Factors contributing to the rise in such diseases include climate change, antimicrobial resistance, weakened immune systems, and environmental disturbances. Microbial identification plays a crucial role in accurate diagnosis, targeted treatment, disease surveillance, outbreak control, and antimicrobial management. For example, in March 2024, the Centers for Disease Control and Prevention (CDC) reported that tuberculosis cases in the U.S. grew from 8,320 in 2022 to 9,615 in 2023, showing an increase of 1,295 cases, driving the microbial identification market.
The microbial identification market covered in this report is segmented –
1) By Products And Services: Instruments, Consumables, Services
2) By Methods: Phenotypic Methods, Proteotypic Methods, Genotypic Methods
3) By Application: Diagnostic Application, Environmental Application, Food and Beverages Testing, Pharmaceutical Application, Other Applications
4) By End User: Pharmaceutical And Biotechnology Industry, Food And Beverage Industry, Water And Environment Industry, Independent Research Laboratories, Diagnostic Laboratories, Hospitals, Other End Users
Subsegments:
1) By Instruments: Mass Spectrometers ( Maldi-Tof), Chromatography Systems, Pcr Systems, Microplate Readers, Automated Identification Systems
2) By Consumables: Reagents And Kits ( Pcr Reagents, Biochemical Reagents), Culture Media, Sample Collection Tools ( Swabs, Vials), Test Strips
3) By Services: Microbial Identification Services ( Laboratory Testing), Consulting And Training Services, Technical Support Services, Data Analysis Services
Major firms in the microbial identification industry are innovating with solutions such as sample preparation platforms, which help to increase speed and precision in microbial identification. These rigged systems, utilized for treating and preparing biological or clinical samples for examination, increases proficiency, precision, and speed in diagnostic processes. For instance, in September 2024, an American in vitro diagnostics company called Accelerate Diagnostics Inc, received approval from the FDA for their Accelerate Arc system. This is an advanced, automated solution that rapidly identifies microbes directly from positive blood culture samples. The sample preparation process is automated for microbial identification through the Bruker MALDI Biotyper CA System, significantly reducing the duration of waiting for results, crucial in the diagnosis and treatment of infections like sepsis. This system facilitates quicker microbial identification, enabling clinicians to promptly begin the most effective antibiotic treatment, leading to better patient outcomes and lessening the probability of antimicrobial resistance. Having received FDA clearance, the Accelerate Arc system is aimed at boosting operational efficiency in clinical labs.
Major companies operating in the microbial identification market are:
• Merck & Co. Inc.
• Sanofi S A
• ThermoFisher Scientific Inc.
• Danaher Corporation
• Siemens Healthineers
• Becton
• Dickinson and Company
• Avantor Inc.
• Eurofins Scientific Corporation
• Beckman Coulter Inc.
• VWR International LLC
• Charles River Laboratories International Inc.
• PerkinElmer Inc.
• Wickham Micro Limited
• Bruker Corporation
• BioMerieux S.A.
• Biolog Inc.
• Liofilchem S.r.l
• Shimadzu Corporation
• Scenker Biological Technology Co. Ltd
North America was the largest region in the microbial identification market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the microbial identification market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.